Histological improvement of fibrosis in patients with hepatitis C who achieved a 5-year sustained virological response to treatment with direct-acting antivirals
Long-term SVR to treatment with DAA ameliorated histological liver fibrosis. Noninvasive tests helped predict the degree of liver fibrosis after SVR, but their cut-off values should be redefined to avoid underestimation of liver fibrosis.
Authors
- Takayuki Iwamoto (ORCID: https://orcid.org/0000-0001-5835-5160)
- Shinjiro Yamaguchi (ORCID: https://orcid.org/0000-0002-0786-1757)
- Rui Mizumoto
- Tetsuo Takehara (ORCID: https://orcid.org/0000-0001-5036-3457)
- Yoshiki Ito (ORCID: https://orcid.org/0000-0002-8813-9458)
- Yuki Tahata (ORCID: https://orcid.org/0000-0002-9116-7054)
- Hideki Hagiwara (ORCID: https://orcid.org/0000-0002-8361-1311)
- Yōichi Sasaki (ORCID: https://orcid.org/0000-0002-0619-7970)
- Takanori Inoue (ORCID: https://orcid.org/0000-0001-8247-0230)
- Yoshiko Sudo
- Yuki Arimoto (ORCID: https://orcid.org/0009-0007-0880-5339)
- Hayato Hikita (ORCID: https://orcid.org/0000-0003-2488-7315)
- Machiko Kai
- Takahiro Suda
- Michiko Yoshimura
- Yasutoshi Nozaki
- Takashi Ohta
Institutions
- Kansai Rosai Hospital (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Journal of Gastroenterology
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1007/s00535-024-02165-0
- Citations
- 3
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 1.11